Drugs / NU300
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01732198 | Mar 2013 → Jan 2014 | infectious disease | Nuron Biotech Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NU300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01732198 ↗ |
| Modality | Vaccine | “Investigational Hib Vaccine (NU300)” NCT01732198 ↗ |
| Route | Intramuscular | “NU300 at a single dose of 0.5 mL IM” NCT01732198 ↗ |